Company
Flare Therapeutics
Flare Therapeutics’ pipeline is Initially focused on precision oncology.
Also known as Flare Therapeutics Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Flare Therapeutics Inc.
- flaretx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Flare Therapeutics is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines.
Funding snapshot
- Total raised
- $208MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series C, $85M2026-06-30
Funding rounds
- Series C
- $85M2026-06-30, Company stated
- Series B
- $123M2023-03-22, Company stated
Loading relationship preview